Expression of cyclin B1 in the metaplasia-dysplasia-carcinoma sequence of Barrett esophagus

Cancer

Volumn 94, Issue 1, 2002, Pages 212-218

  Geddert, Helene ^a   Heep, Hans J ^a   Gabbert, Helmut E ^a   Sarbia, Mario ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Barrette esophagus; Carcinoma; Cyclin B1; Dysplasia; Metaplasia

Indexed keywords

CYCLIN B1;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CARCINOGENESIS; CLINICAL ARTICLE; DYSPLASIA; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METAPLASIA; MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CYCLIN B; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; METAPLASIA; MIDDLE AGED;

EID: 0036140608     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10152     Document Type: Article

References (31)

1. Barrett's esophagus, dysplasia, and adenocarcinoma
2. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus
3. A single centre's 20 years' experience of columnar-lined (Barrett's) oesophagus diagnosis
4. Unrestricted cell cycling and cancer
5. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
6. Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport
7. Cyclins, cyclin-dependent kinases and cdk inhibitors: Implications in cell cycle control and cancer
8. Animal cell cycles and their control
9. Flow cytometry study of human cyclin B1 and cyclin E expression in leukemic cell lines: Cell cycle kinetics and cell localization
10. Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines
11. Cyclin-dependent kinase activation and S-phase induction of the cyclin B1 gene are linked through the CCAAT elements
12. cdc2
13. Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: Immunocytochemical and quantitative image analyses
14. Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma
15. Overexpression of cyclin B1 in human colorectal cancers
16. Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma
17. Frequent c-myc amplification in high-grade dysplasia and adenocarcinoma in Barrett's esophagus
18. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus
19. Cytometry of cyclin proteins
20. Apoptotic and proliferative activity in the neoplastic progression of Barrett's oesophagus: A comparative study
21. Analysis of Ki-67, p53 and Bcl-2 expression in the dysplasia-carcinoma sequence of Barrett's esophagus
22. Redundant cyclin overexpression and gene amplification in breast cancer cells
23. p53 regulates a G2 checkpoint through cyclin B1
24. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest
25. Recent developments in the molecular characterization of Barrett's esophagus
26. Observer variation in the diagnosis of dysplasia in Barrett's esophagus
27. Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice
28. Clinical decision making in Barrett's oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation
29. Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus